In recent years, it has been shown that the provision of dietary phosphate lowering education as an early therapeutic strategy to lower phosphate uptake during the early stages of GFR decline may reduce fibroblast growth factor 23 levels and thus delay disease progression and the development of CKD-Mineral Bone Disorder [12–14]. Here, FGF23 is linked to abnormal mineralization disorder.